We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 485 results
  1. The multimodal imaging features and outcomes of multifocal choroiditis/punctate inner choroidopathy lesion with multiple evanescent white dot syndrome-like features: a retrospective study

    Background

    Multiple evanescent white dot syndrome (MEWDS)-like features is a rare condition triggered by a macular disease or iatrogenic injury,...

    Chunli Chen, Yizhe Cheng, ... **aoyan Peng in BMC Ophthalmology
    Article Open access 02 January 2024
  2. Influence of lesion location on lesion reactivation after initial treatment in neovascular age-related macular degeneration

    Purpose

    We aim to evaluate the factors associated with the incidence of lesion reactivation after initial loading injections in patients with...

    Jae Hui Kim, Jong Woo Kim, Chul Gu Kim in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 14 June 2023
  3. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME)

    Introduction

    The aims of this work were to evaluate the real-world efficacy and safety of a loading dose of intravitreal faricimab in eyes with active...

    Ermete Giancipoli, Antonella Guglielmi, ... Cristiana Iaculli in Ophthalmology and Therapy
    Article Open access 04 June 2024
  4. Result of intravitreal aflibercept injection for myopic choroidal neovascularization

    Background

    The current study aimed to evaluate the efficacy of intravitreal aflibercept injections as the primary treatment for subfoveal/juxtafoveal...

    Shih-Lin Chen, Pei-Ling Tang, Tsung-Tien Wu in BMC Ophthalmology
    Article Open access 22 September 2021
  5. Subretinal leakage of a retinal capillary macroaneurysm - a case report

    Background

    Report a rare case of retinal capillary macroaneurysm with associated subretinal fluid.

    Case presentation

    A 71-year-old male underwent full...

    Ahmad S. Rehmani, Touka Banaee, Fuad Makkouk in BMC Ophthalmology
    Article Open access 17 May 2021
  6. Predictive factors of age-related macular degeneration with poor response to three loading doses of anti-vascular endothelial growth factor

    Purpose

    To evaluate the predictive factors of neovascular age-related macular degeneration (nAMD) with poor response to three loading doses of...

    Ayna Sariyeva Ismayilov, Yusuf Duru, ... Mahmut Oğuz Ulusoy in International Ophthalmology
    Article 24 June 2024
  7. Treatment of myopic choroidal neovascularization: a network meta-analysis and review

    Purpose

    This is, to our knowledge, the first network meta-analysis aiming to compare all treatment modalities for myopic choroidal neovascularization...

    Laura Glachs, Stefan Embacher, ... Laura Posch-Pertl in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article Open access 11 November 2023
  8. Long-term follow-up of management of choroidal neovascularisation secondary to angioid streaks with intravitreal anti-vascular endothelial growth factor

    Purpose

    To assess the short-term and long-term visual outcomes in patients with choroidal neovascularisation (CNV) secondary to angioid streaks...

    Thushanthi Ramakrishnan, Shruti Chandra, Sobha Sivaprasad in Eye
    Article 28 May 2020
  9. Infographic: intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration (VIEW 1 and VIEW 2)

    Karl Gerard R. Crisostomo, Justine Karl Patrick C. Dantes, ... Jose Carlo M. Artiaga in Eye
    Article 28 November 2023
  10. Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes

    Intravitreal anti–vascular endothelial growth factor (VEGF) therapy is the standard of care for diabetic macular edema (DME) and neovascular...

    Hansjürgen Agostini, Francis Abreu, ... Peter D. Westenskow in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article Open access 07 June 2024
  11. Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study

    Introduction

    To investigate changes in the vitreoretinal interface after anti-vascular endothelial growth factor (anti-VEGF) treatment in highly...

    Mei-Chi Tsui, Yi-Ting Hsieh, ... Tzyy-Chang Ho in Ophthalmology and Therapy
    Article Open access 01 April 2023
  12. Solar maculopathy secondary to sunlight exposure reflected from the screen of mobile devices: two case reports

    Background

    Solar maculopathy is a well described clinical entity that usually occurs in patients that have gazed directly the sun. In this report we...

    Joaquín Marticorena, Ana Honrubia, Javier Ascaso in Journal of Medical Case Reports
    Article Open access 06 September 2022
  13. Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up

    Background

    Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal...

    Jiyang Tang, **nyao Han, ... **feng Qu in BMC Ophthalmology
    Article Open access 21 June 2022
  14. Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab

    Purpose

    To compare results of treatment with bevacizumab and ranibizumab injections in myopic choroidal neovascularization (mCNV).

    Methods ...
    Malgorzata Woronkowicz, Robin Hamilton, ... Oren Tomkins-Netzer in International Ophthalmology
    Article 15 June 2023
  15. Improving clinical management of macular neovascularisation secondary to angioid streaks

    Godhuli Patri, Ibtesam Elaroud, ... Savita Madhusudhan in Eye
    Article Open access 28 November 2023
  16. Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-Therapie

    Background

    Choroidal osteoma (CO) is a benign ossifying ocular tumor, which is unilateral in most cases. The CO may cause severe visual impairment,...

    M. Dütsch, H. Helbig, ... T. Barth in Die Ophthalmologie
    Article Open access 03 September 2023
  17. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization

    Purpose

    To evaluate anatomical and visual results of eyes with naive myopic choroidal neovascularization (mCNV) in patients treated with intravitreal...

    Buğra Karasu, Ali Rıza Cenk Celebi in International Ophthalmology
    Article 31 March 2022
  18. Ranibizumab

    Article 04 September 2021
  19. Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy

    Background

    Long-term results of photodynamic therapy (PDT) combined with vascular endothelial growth factor (VEGF) inhibitors for pachychoroid...

    Yoko Nomura, Shuichiro Aoki, ... Ryo Obata in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 09 May 2024
  20. Visuelle Pseudohalluzinationen Während Ohrakupunktur

    In an unselected, consecutive group of twelve patients who were treated for eye problems with ear acupuncture, the patients described that...

    Article 26 March 2024
Did you find what you were looking for? Share feedback.